Asymmetric dimethylarginine and coronary collateral vessel development

Kocaman S. A., ŞAHİNARSLAN A., BİBEROĞLU G., Hasanoglu A., Akyel A., Timurkaynak T., ...Daha Fazla

CORONARY ARTERY DISEASE, cilt.19, sa.7, ss.469-474, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Sayı: 7
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1097/mca.0b013e328311d32b
  • Dergi Adı: CORONARY ARTERY DISEASE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.469-474
  • Anahtar Kelimeler: asymmetric dimethylarginine, collateral, coronary artery disease, endothelial dysfunction, nitric oxide, L-ARGININE, ENDOTHELIAL DYSFUNCTION, DIABETES-MELLITUS, ARTERY-DISEASE, RISK, ANGIOGENESIS, EVENTS
  • Gazi Üniversitesi Adresli: Evet

Özet

Introduction Nitric oxide (NO) plays a major role in collateral vessel development. Asymmetric dimethylarginine (ADMA) that is an endogenous inhibitor of NO synthesis may impair the effective coronary collateral vessel development. The aim of this study was to evaluate the relationship between plasma ADMA level and coronary collateral vessel development.